https://www.selleckchem.com/pr....oducts/ro-61-8048.ht
Lymphedema and fibrosis (LEF) are common yet overlooked late effects of head and neck cancer and its therapy. Lack of reliable and valid measures of head and neck LEF is a critical barrier to the timely identification and management of head and neck LEF. To fill this gap, we developed and pilot tested a 64-item patient-reported outcome measure ( Lymphedema Symptom Intensity and Distress Survey-Head and Neck, LSIDS-HN). This article aims to report the process of further validation and refinement of the tool. A prospective, longit
Like
Comment
Share
